Literature DB >> 25657313

Dissecting the roles of microRNAs in coronary heart disease via integrative genomic analyses.

Tianxiao Huan1, Jian Rong1, Kahraman Tanriverdi1, Qingying Meng1, Anindya Bhattacharya1, David D McManus1, Roby Joehanes1, Themistocles L Assimes1, Ruth McPherson1, Nilesh J Samani1, Jeanette Erdmann1, Heribert Schunkert1, Paul Courchesne1, Peter J Munson1, Andrew D Johnson1, Christopher J O'Donnell1, Bin Zhang1, Martin G Larson1, Jane E Freedman2, Daniel Levy1, Xia Yang1.   

Abstract

OBJECTIVE: The roles of microRNAs (miRNAs) in coronary heart disease (CHD) have not been well characterized. This study sought to systematically characterize the complex genomic architecture of CHD by integrating whole blood miRNA and mRNA expression with genetic variation in 186 CHD cases and 186 controls. APPROACH AND
RESULTS: At false discovery rate <0.2, 15 miRNAs were differentially expressed between CHD cases and controls. To explore regulatory mechanisms, we integrated miRNA and mRNA expression with genome-wide genotype data to investigate miRNA and mRNA associations and relationships of genetic variation with miRNAs. We identified a large number of correlated miRNA-mRNA pairs and genetic loci that seem to regulate miRNA levels. Subsequently, we explored the relationships of these complex molecular associations with CHD status. We identified a large difference in miRNA-mRNA associations between CHD cases and controls, as demonstrated by a significantly higher proportion of inversely correlated miRNA-mRNA pairs in cases versus controls (80% versus 30%; P<1×10(-16)), suggesting a genome-wide shift in the regulatory structure of the transcriptome in CHD. The differentially coexpressed miRNA-mRNA pairs showed enrichment for CHD risk genetic variants affecting both miRNA and mRNA expression levels, implicating a putatively causal role in CHD. Furthermore, 3 miRNAs (miR-1275, miR-365a-3p, and miR-150-5p) were associated with an mRNA coexpression module that was causally linked to CHD and reflected the dysregulation of B-cell centered immune function.
CONCLUSIONS: Our results provide novel evidence that miRNAs are important regulators of biological processes involved in CHD via genetic control and via their tight coexpression with mRNAs.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  coronary disease; genetics; systems biology

Mesh:

Substances:

Year:  2015        PMID: 25657313      PMCID: PMC4376567          DOI: 10.1161/ATVBAHA.114.305176

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  52 in total

Review 1.  Genomics of cardiovascular disease.

Authors:  Christopher J O'Donnell; Elizabeth G Nabel
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Serum levels of microRNAs in patients with heart failure.

Authors:  Yaron Goren; Michal Kushnir; Barak Zafrir; Sarit Tabak; Basil S Lewis; Offer Amir
Journal:  Eur J Heart Fail       Date:  2011-11-25       Impact factor: 15.534

3.  Refining the role of B cells in atherosclerosis.

Authors:  Heather M Perry; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07       Impact factor: 8.311

4.  microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans.

Authors:  K Bidzhekov; L Gan; B Denecke; A Rostalsky; M Hristov; T A Koeppel; A Zernecke; C Weber
Journal:  Thromb Haemost       Date:  2012-02-28       Impact factor: 5.249

Review 5.  Progress and challenges in translating the biology of atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

6.  Genetic architecture of microRNA expression: implications for the transcriptome and complex traits.

Authors:  Eric R Gamazon; Dana Ziliak; Hae Kyung Im; Bonnie LaCroix; Danny S Park; Nancy J Cox; R Stephanie Huang
Journal:  Am J Hum Genet       Date:  2012-05-31       Impact factor: 11.025

7.  A systems biology framework identifies molecular underpinnings of coronary heart disease.

Authors:  Tianxiao Huan; Bin Zhang; Zhi Wang; Roby Joehanes; Jun Zhu; Andrew D Johnson; Saixia Ying; Peter J Munson; Nalini Raghavachari; Richard Wang; Poching Liu; Paul Courchesne; Shih-Jen Hwang; Themistocles L Assimes; Ruth McPherson; Nilesh J Samani; Heribert Schunkert; Qingying Meng; Christine Suver; Christopher J O'Donnell; Jonathan Derry; Xia Yang; Daniel Levy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-28       Impact factor: 8.311

8.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.

Authors:  Heribert Schunkert; Inke R König; Sekar Kathiresan; Muredach P Reilly; Themistocles L Assimes; Hilma Holm; Michael Preuss; Alexandre F R Stewart; Maja Barbalic; Christian Gieger; Devin Absher; Zouhair Aherrahrou; Hooman Allayee; David Altshuler; Sonia S Anand; Karl Andersen; Jeffrey L Anderson; Diego Ardissino; Stephen G Ball; Anthony J Balmforth; Timothy A Barnes; Diane M Becker; Lewis C Becker; Klaus Berger; Joshua C Bis; S Matthijs Boekholdt; Eric Boerwinkle; Peter S Braund; Morris J Brown; Mary Susan Burnett; Ian Buysschaert; John F Carlquist; Li Chen; Sven Cichon; Veryan Codd; Robert W Davies; George Dedoussis; Abbas Dehghan; Serkalem Demissie; Joseph M Devaney; Patrick Diemert; Ron Do; Angela Doering; Sandra Eifert; Nour Eddine El Mokhtari; Stephen G Ellis; Roberto Elosua; James C Engert; Stephen E Epstein; Ulf de Faire; Marcus Fischer; Aaron R Folsom; Jennifer Freyer; Bruna Gigante; Domenico Girelli; Solveig Gretarsdottir; Vilmundur Gudnason; Jeffrey R Gulcher; Eran Halperin; Naomi Hammond; Stanley L Hazen; Albert Hofman; Benjamin D Horne; Thomas Illig; Carlos Iribarren; Gregory T Jones; J Wouter Jukema; Michael A Kaiser; Lee M Kaplan; John J P Kastelein; Kay-Tee Khaw; Joshua W Knowles; Genovefa Kolovou; Augustine Kong; Reijo Laaksonen; Diether Lambrechts; Karin Leander; Guillaume Lettre; Mingyao Li; Wolfgang Lieb; Christina Loley; Andrew J Lotery; Pier M Mannucci; Seraya Maouche; Nicola Martinelli; Pascal P McKeown; Christa Meisinger; Thomas Meitinger; Olle Melander; Pier Angelica Merlini; Vincent Mooser; Thomas Morgan; Thomas W Mühleisen; Joseph B Muhlestein; Thomas Münzel; Kiran Musunuru; Janja Nahrstaedt; Christopher P Nelson; Markus M Nöthen; Oliviero Olivieri; Riyaz S Patel; Chris C Patterson; Annette Peters; Flora Peyvandi; Liming Qu; Arshed A Quyyumi; Daniel J Rader; Loukianos S Rallidis; Catherine Rice; Frits R Rosendaal; Diana Rubin; Veikko Salomaa; M Lourdes Sampietro; Manj S Sandhu; Eric Schadt; Arne Schäfer; Arne Schillert; Stefan Schreiber; Jürgen Schrezenmeir; Stephen M Schwartz; David S Siscovick; Mohan Sivananthan; Suthesh Sivapalaratnam; Albert Smith; Tamara B Smith; Jaapjan D Snoep; Nicole Soranzo; John A Spertus; Klaus Stark; Kathy Stirrups; Monika Stoll; W H Wilson Tang; Stephanie Tennstedt; Gudmundur Thorgeirsson; Gudmar Thorleifsson; Maciej Tomaszewski; Andre G Uitterlinden; Andre M van Rij; Benjamin F Voight; Nick J Wareham; George A Wells; H-Erich Wichmann; Philipp S Wild; Christina Willenborg; Jaqueline C M Witteman; Benjamin J Wright; Shu Ye; Tanja Zeller; Andreas Ziegler; Francois Cambien; Alison H Goodall; L Adrienne Cupples; Thomas Quertermous; Winfried März; Christian Hengstenberg; Stefan Blankenberg; Willem H Ouwehand; Alistair S Hall; Panos Deloukas; John R Thompson; Kari Stefansson; Robert Roberts; Unnur Thorsteinsdottir; Christopher J O'Donnell; Ruth McPherson; Jeanette Erdmann; Nilesh J Samani
Journal:  Nat Genet       Date:  2011-03-06       Impact factor: 38.330

9.  Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*.

Authors:  Brigitte M Sondermeijer; Annemieke Bakker; Amalia Halliani; Maurice W J de Ronde; Arnoud A Marquart; Anke J Tijsen; Ties A Mulders; Maayke G M Kok; Suzanne Battjes; Steffi Maiwald; Suthesh Sivapalaratnam; Mieke D Trip; Perry D Moerland; Joost C M Meijers; Esther E Creemers; Sara-Joan Pinto-Sietsma
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

10.  TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support.

Authors:  Thanasis Vergoulis; Ioannis S Vlachos; Panagiotis Alexiou; George Georgakilas; Manolis Maragkakis; Martin Reczko; Stefanos Gerangelos; Nectarios Koziris; Theodore Dalamagas; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

View more
  29 in total

Review 1.  Developing Peripheral Blood Gene Expression-Based Diagnostic Tests for Coronary Artery Disease: a Review.

Authors:  Brian Rhees; James A Wingrove
Journal:  J Cardiovasc Transl Res       Date:  2015-06-25       Impact factor: 4.132

2.  Epigenome-wide association study of DNA methylation and microRNA expression highlights novel pathways for human complex traits.

Authors:  Tianxiao Huan; Michael Mendelson; Roby Joehanes; Chen Yao; Chunyu Liu; Ci Song; Anindya Bhattacharya; Jian Rong; Kahraman Tanriverdi; Joshua Keefe; Joanne M Murabito; Paul Courchesne; Martin G Larson; Jane E Freedman; Daniel Levy
Journal:  Epigenetics       Date:  2019-07-17       Impact factor: 4.528

3.  Reduced atherosclerosis lesion size, inflammatory response in miR-150 knockout mice via macrophage effects.

Authors:  Fu-Han Gong; Wen-Lin Cheng; Haiping Wang; Maomao Gao; Juan-Juan Qin; Yan Zhang; Xia Li; Xueyong Zhu; Hao Xia; Zhi-Gang She
Journal:  J Lipid Res       Date:  2018-02-20       Impact factor: 5.922

Review 4.  Gene Expression Signatures and the Spectrum of Coronary Artery Disease.

Authors:  Kevin A Friede; Geoffrey S Ginsburg; Deepak Voora
Journal:  J Cardiovasc Transl Res       Date:  2015-06-19       Impact factor: 4.132

Review 5.  Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Trends Cardiovasc Med       Date:  2016-07-28       Impact factor: 6.677

Review 6.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06

Review 7.  Systems Biology and Noninvasive Imaging of Atherosclerosis.

Authors:  Claudia Calcagno; Willem J M Mulder; Matthias Nahrendorf; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02       Impact factor: 8.311

Review 8.  Personalized medicine in thrombosis: back to the future.

Authors:  Srikanth Nagalla; Paul F Bray
Journal:  Blood       Date:  2016-02-04       Impact factor: 22.113

Review 9.  70-year legacy of the Framingham Heart Study.

Authors:  Charlotte Andersson; Andrew D Johnson; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2019-11       Impact factor: 32.419

Review 10.  Systems genetics applications in metabolism research.

Authors:  Marcus Seldin; Xia Yang; Aldons J Lusis
Journal:  Nat Metab       Date:  2019-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.